News

George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

Home March 10, 2015
Home
News

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March 10 issue of JAMA. Of those alive at 12 months, almost half had not been rehospitalized and approximately 25 percent had only one hospitalization.

Home March 10, 2015
Home
News

Carestream is demonstrating its new Touch Ultrasound System at the American Institute of Ultrasound in Medicine (AIUM) annual meeting, March 21-25.

Home March 09, 2015
Home
News

TeraRecon unveiled the latest release of the company’s flagship iNtuition enterprise viewing solutions in combination with the second-generation of its iNteract+ interoperability platform at the annual European Congress of Radiology (ECR) meeting, March 4-8 in Vienna.

Home March 09, 2015
Home
VTEC, NYU Langone, venous therapies, deep vein thrombosis, DVT, PE
Feature

NYU Langone Medical Center has announced the creation of a new multidisciplinary Venous Thromboembolic Disease Center (VTEC) to treat those with life-threatening blood clots. The new VTEC delivers advanced detection, comprehensive care and effective management for patients experiencing a venous thromboembolic event.

Home March 09, 2015
Home
atrial fibrillation, women, seniors, guidelines, blood thinners, DCRI
Feature

Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research Institute (DCRI).

Home March 09, 2015
Home
Technology

The U.S. Food and Drug Administration (FDA) approved the ResQCPR System, a system of two devices for first responders to use while performing cardiopulmonary resuscitation (CPR) on cardiac arrest patients. The devices may improve the patient’s chances of surviving cardiac arrest.

Home March 09, 2015
Home
News

March 9, 2015 — Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by ...

Home March 09, 2015
Home
News

Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies (CRT) conference in Washington, D.C. The BIOFLEX-I trial is designed to support U.S. Food and Drug Administration (FDA) approval of the Astron self-expanding nitinol stent to treat patients suffering from common iliac or external iliac artery disease.

Home March 09, 2015
Home
Technology

AliveCor Inc. announced the launch of the latest version of the AliveECG app, which instantly detects when an electrocardiogram (ECG) is either normal or unreadable.

Home March 09, 2015
Home
News

Fujifilm Medical Systems U.S.A. Inc. will demonstrate the latest version of Synapse Cardiovascular 6.0 and Synapse 3-D 4.1 at the American College of Cardiology (ACC) 64th Annual Scientific Session & Expo on March 14 -16 in San Diego, California.

Home March 09, 2015
Home
News

Corindus Vascular Robotics Inc. announced it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the Medical University of Graz in Graz, Austria, and is led by Prof. Marianne Brodmann, M.D., a leading researcher with the university’s Division of Angiology, in combination with Prof. Hannes Deutschmann, M.D., of the Medical University of Graz Department of Radiology, and study chairman, Ehtisham Mahmud, M.D., director, Sulpizio Cardiovascular Center-Medicine, UC San Diego.

Home March 09, 2015
Home
Technology

Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.

Home March 06, 2015
Home
Technology

The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full set of clinical prevention guidelines released by ACC/American Heart Association in 2013.

Home March 06, 2015
Home
News

Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar), one of the largest secondary prevention studies of an antiplatelet medicine.

Home March 06, 2015
Home
Subscribe Now